Matches in Wikidata for { <http://www.wikidata.org/entity/Q37037022> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- Q37037022 description "article científic" @default.
- Q37037022 description "article scientifique" @default.
- Q37037022 description "articolo scientifico" @default.
- Q37037022 description "artigo científico" @default.
- Q37037022 description "artículu científicu espublizáu en 2016" @default.
- Q37037022 description "bilimsel makale" @default.
- Q37037022 description "scientific article published on May 2016" @default.
- Q37037022 description "vedecký článok" @default.
- Q37037022 description "vetenskaplig artikel" @default.
- Q37037022 description "videnskabelig artikel" @default.
- Q37037022 description "vědecký článek" @default.
- Q37037022 description "wetenschappelijk artikel" @default.
- Q37037022 description "wissenschaftlicher Artikel" @default.
- Q37037022 description "наукова стаття, опублікована в травні 2016" @default.
- Q37037022 description "научни чланак" @default.
- Q37037022 description "مقالة علمية نشرت في مايو 2016" @default.
- Q37037022 name "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 name "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 name "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 type Item @default.
- Q37037022 label "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 label "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 label "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 prefLabel "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 prefLabel "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 prefLabel "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 P1433 Q37037022-CCFB25DD-DAFE-4D1D-A0E4-61ECB71FC7A4 @default.
- Q37037022 P1476 Q37037022-985C27E3-7E54-41D9-BF9D-020EE650A89B @default.
- Q37037022 P2093 Q37037022-3BE08A97-35DB-4EE2-A8BB-129B45A87F86 @default.
- Q37037022 P2093 Q37037022-781F8701-B88D-4A0C-AA1D-ACCB53BBA185 @default.
- Q37037022 P2860 Q37037022-0063080E-7701-42CB-B4AD-5A7924AE87F3 @default.
- Q37037022 P2860 Q37037022-224F920A-D9C9-468D-B71D-8FCB61AFEB6B @default.
- Q37037022 P2860 Q37037022-39410569-E39A-4629-9DF4-836BDA9C4008 @default.
- Q37037022 P2860 Q37037022-3A418A10-6538-4B18-A7AD-E7A877FEDE3F @default.
- Q37037022 P2860 Q37037022-3C0B0488-134D-4362-8C5D-CBDDA462F64B @default.
- Q37037022 P2860 Q37037022-3F378407-8C2A-4BD1-BDF4-F7EB57A6B6F9 @default.
- Q37037022 P2860 Q37037022-3FE6D9C5-C3E6-4457-BADF-9108AF1BD66A @default.
- Q37037022 P2860 Q37037022-4F6D1851-EB2F-4010-8AB5-2FB1C2037536 @default.
- Q37037022 P2860 Q37037022-502997C8-1C9B-491B-9227-AAD9E8BD7AA5 @default.
- Q37037022 P2860 Q37037022-52D03D75-0B23-4C37-88CB-F400054B06C8 @default.
- Q37037022 P2860 Q37037022-59039236-E901-423F-91DE-6FB2131124EA @default.
- Q37037022 P2860 Q37037022-6EF5CE1D-ED63-48DC-8E5C-838B2AD65794 @default.
- Q37037022 P2860 Q37037022-7501F0EB-DEDF-4B47-AC0B-CF4AC9866AE2 @default.
- Q37037022 P2860 Q37037022-7643C452-B9A4-4214-8F49-F70D9EE5C7EE @default.
- Q37037022 P2860 Q37037022-7D72F8D3-02FF-4333-B70A-E9C5FD37166F @default.
- Q37037022 P2860 Q37037022-850B2F23-FB93-4894-94F9-141523699E91 @default.
- Q37037022 P2860 Q37037022-8EF260D1-4EB2-4C79-A6E3-7E59A2A10BB0 @default.
- Q37037022 P2860 Q37037022-9A5ED81A-1938-469C-A30B-8ACAA8984349 @default.
- Q37037022 P2860 Q37037022-B0D4FD2A-F7E2-46AA-B61E-F630C4BEAECA @default.
- Q37037022 P2860 Q37037022-DE9467FB-5648-46D3-93EB-C3353FF39E16 @default.
- Q37037022 P304 Q37037022-DC933049-7C1F-4C44-BE89-31B232D32A7D @default.
- Q37037022 P31 Q37037022-9A6BFF37-73A9-4454-89BC-9A21C99F52D6 @default.
- Q37037022 P356 Q37037022-C6E67E21-DAAD-47BB-A3B4-E4C47D0179DB @default.
- Q37037022 P433 Q37037022-7C36D974-1263-4A4C-ADC7-B1F001C055B3 @default.
- Q37037022 P478 Q37037022-745031B0-FA38-4465-9CED-AE38783E3115 @default.
- Q37037022 P577 Q37037022-44C714A3-B5C1-4A9C-9DA7-F4F85A189E28 @default.
- Q37037022 P698 Q37037022-053A2882-6334-49D4-B827-0888A35785E0 @default.
- Q37037022 P921 Q37037022-F9F01CA1-2FC2-4034-AA7A-59E6FC65D538 @default.
- Q37037022 P932 Q37037022-473809CB-37DF-434D-BA12-D1EB7FEAFA2B @default.
- Q37037022 P356 S1677-5538.IBJU.2016.03.04 @default.
- Q37037022 P698 27286102 @default.
- Q37037022 P1433 Q26841933 @default.
- Q37037022 P1476 "Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No." @default.
- Q37037022 P2093 "Nathan Lawrentschuk" @default.
- Q37037022 P2093 "Nishanth Krishnananthan" @default.
- Q37037022 P2860 Q24647380 @default.
- Q37037022 P2860 Q33985455 @default.
- Q37037022 P2860 Q34629234 @default.
- Q37037022 P2860 Q35725546 @default.
- Q37037022 P2860 Q36194308 @default.
- Q37037022 P2860 Q36520490 @default.
- Q37037022 P2860 Q38184680 @default.
- Q37037022 P2860 Q38194533 @default.
- Q37037022 P2860 Q38194868 @default.
- Q37037022 P2860 Q39143853 @default.
- Q37037022 P2860 Q39391979 @default.
- Q37037022 P2860 Q39958888 @default.
- Q37037022 P2860 Q40353211 @default.
- Q37037022 P2860 Q41560886 @default.
- Q37037022 P2860 Q46511086 @default.
- Q37037022 P2860 Q46749786 @default.
- Q37037022 P2860 Q47249499 @default.
- Q37037022 P2860 Q57696209 @default.
- Q37037022 P2860 Q63966753 @default.
- Q37037022 P2860 Q86202651 @default.
- Q37037022 P304 "418-421" @default.
- Q37037022 P31 Q13442814 @default.
- Q37037022 P356 "10.1590/S1677-5538.IBJU.2016.03.04" @default.
- Q37037022 P433 "3" @default.
- Q37037022 P478 "42" @default.
- Q37037022 P577 "2016-05-01T00:00:00Z" @default.
- Q37037022 P698 "27286102" @default.
- Q37037022 P921 Q181257 @default.
- Q37037022 P932 "4920556" @default.